CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION

被引:557
作者
DAI, YF
SCHWARZ, EM
GU, DL
ZHANG, WW
SARVETNICK, N
VERMA, IM
机构
[1] SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
[2] Scripps Res Inst, DEPT NEUROPHARMACOL CVN10, LA JOLLA, CA 92037 USA
[3] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT THORAC CANC & CARDIOVASC SURG, HOUSTON, TX 77030 USA
关键词
D O I
10.1073/pnas.92.5.1401
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recombinant adenoviruses containing the canine factor IX (FIX) cDNA were directly introduced in the hind leg muscle of mice, We show that (i) in nude mice, high expression (1-5 mu g/ml in plasma) of FIX protein can be detected for >300 days; (ii) in contrast, expression of FIX protein was transient (7-10 days) in normal mice; (iii) CD8(+) lymphocytes could be detected within 3 days in the infected muscle tissue; (iv) use of beta(2)-microglobulin and immunoglobulin M heavy chain ''knockout'' mice showed that lack of sustained expression of FIX protein is due to cell-mediated and humoral immune responses; (v) normal mice, once infected with recombinant adenovirus, could not be reinfected efficiently for at least 30 days due to neutralizing viral antibodies; and, finally, (vi) using immunosuppressive drugs, some normal mice can be tolerized to produce and secrete FIX protein for >5 months. We conclude that currently available adenoviral vectors have serious limitations for use for longterm gene therapy.
引用
收藏
页码:1401 / 1405
页数:5
相关论文
共 25 条
  • [1] PHENOTYPIC CORRECTION OF FACTOR-IX DEFICIENCY IN SKIN FIBROBLASTS OF HEMOPHILIC DOGS
    AXELROD, JH
    READ, MS
    BRINKHOUS, KM
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (13) : 5173 - 5177
  • [2] GENE-THERAPY VIA PRIMARY MYOBLASTS - LONG-TERM EXPRESSION OF FACTOR-IX PROTEIN FOLLOWING TRANSPLANTATION INVIVO
    DAI, Y
    ROMAN, M
    NAVIAUX, RK
    VERMA, IM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10892 - 10895
  • [3] ADENOVIRUS-MEDIATED TRANSFER OF THE CFTR GENE TO LUNG OF NONHUMAN-PRIMATES - BIOLOGICAL EFFICACY STUDY
    ENGELHARDT, JF
    SIMON, RH
    YANG, YP
    ZEPEDA, M
    WEBERPENDLETON, S
    DORANZ, B
    GROSSMAN, M
    WILSON, JM
    [J]. HUMAN GENE THERAPY, 1993, 4 (06) : 759 - 769
  • [4] ENGELHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6193
  • [5] Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109
  • [6] CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5
    GRAHAM, FL
    SMILEY, J
    RUSSELL, WC
    NAIRN, R
    [J]. JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) : 59 - 72
  • [7] GREEN D, 1991, AM J MED, V91, pS14
  • [8] HYPERCHOLESTEROLEMIA IN LOW-DENSITY-LIPOPROTEIN RECEPTOR KNOCKOUT MICE AND ITS REVERSAL BY ADENOVIRUS-MEDIATED GENE DELIVERY
    ISHIBASHI, S
    BROWN, MS
    GOLDSTEIN, JL
    GERARD, RD
    HAMMER, RE
    HERZ, J
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (02) : 883 - 893
  • [9] ADENOVIRUS-MEDIATED INVIVO GENE-TRANSFER AND EXPRESSION IN NORMAL RAT-LIVER
    JAFFE, HA
    DANEL, C
    LONGENECKER, G
    METZGER, M
    SETOGUCHI, Y
    ROSENFELD, MA
    GANT, TW
    THORGEIRSSON, SS
    STRATFORDPERRICAUDET, LD
    PERRICAUDET, M
    PAVIRANI, A
    LECOCQ, JP
    CRYSTAL, RG
    [J]. NATURE GENETICS, 1992, 1 (05) : 372 - 378
  • [10] A B-CELL-DEFICIENT MOUSE BY TARGETED DISRUPTION OF THE MEMBRANE EXON OF THE IMMUNOGLOBULIN MU-CHAIN GENE
    KITAMURA, D
    ROES, J
    KUHN, R
    RAJEWSKY, K
    [J]. NATURE, 1991, 350 (6317) : 423 - 426